Antipsychotic-induced urinary dysfunction: Anticholinergic effect or otherwise?

BMJ Case Reports

Volumn , Issue , 2009, Pages

  Saddichha, Sahoo ^a   Kumar, Manoj ^b  

^a EMRI   (India)

^b INSTITUTE OF HUMAN BEHAVIOUR AND ALLIED SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84896535738     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr.02.2009.1547     Document Type: Article

References (18)

1. Ambrosini PJ, Nurnberg HG. Urinary incontinence and neuroleptics. Am J Psychiatry 1982; 139: 539.
2. Ambrosini PJ. A pharmacological paradigm for urinary incontinence and enuresis. J Clin Psychopharmacol 1984; 4: 247-253. (Pubitemid 14013145)
3. Vernon LT, Fuller MA, Hattab H, et al. Olanzapine-induced urinary incontinence: treatment with ephedrine. J Clin Psychiatry 2000; 61: 601-2.
4. Sagar R, Varghese ST, Balhara YP. Olanzapine-induced double incontinence. Indian J Med Sci 2005; 59: 163-4.
5. Benazzi F. Urinary retention with fluoxetine-haloperidol combination in a young patient. Can J Psychiatry 1996; 41: 606-7.
6. Kiruluta HG, Andrews K. Urinary incontinence secondary to drugs. Urology 1983; 22: 88-90. (Pubitemid 13026497)
7. Sahoo S. Aripiprazole in a patient susceptible to urinary side effects of antipsy chotics. Isr J Psychiatry Relat Sci 2007; 44: 74-5.
8. Fuller MA, Borov icka MC, Jaskiw GE, et al. Clozapine-induced urinary incontinence: incidence and treatment with ephedrine. J Clin Psychiatry 1996; 57: 514-8. (Pubitemid 26412502)
9. Schwarcz G. Pre-existing unihibited bladder facilitating drug-induced enuresis: four case reports. Can J Psychiatry 1983; 28: 489-90. (Pubitemid 14249247)
10. Shenoy RS. Nocturnal enuresis caused by psy chotropic drugs. Am J Psychiatry 1980; 137: 739-40. (Pubitemid 10121012)
11. Hsu JW, Wang YC, Lin CC, et al. No ev idence for association of alpha 1a adrenoceptor gene poly morphism and clozapine induced urinary incontinence. Neuropsychobiology 2000; 42: 62-5.
12. Renshaw DC. Thioridazine and incontinence. JAMA 1971; 218: 738.
13. Bondy B, Zill P. Psy chopharmacogenetics-a challenge for pharmacotherapy in psy chiatry. World J Biol Psychiatry 2001; 2: 178-83.
14. Yoshimura N, Mizuta E, Kuno S, et al. The dopamine D1 receptor agonist SKF 38393 suppresses detrusor hyperref lexia in the monkey with parkinsonism induced by 1-methy l-4-pheny l-1,2,3,6-tetrahy dropy ridine (MPTP). Neuropharmacology 1993; 32: 315-21. (Pubitemid 23122630)
15. Gardner DM, Baldessarini RJ, Waraich P. Modern antipsy chotic drugs: A critical overview. CMAJ 2005; 172: 1703-11. (Pubitemid 40896865)
16. Schwinn DA. The role of 1-adrenergic receptor subtypes in lower urinary tract symptoms. BJU Int 2001; 88: 27-34. (Pubitemid 32955448)
17. Burris KD, Molski TF, Ry an E, et al. Aripiprazole, a novel antipsy chotic, is a high-affinity partial agonist at human dopamine D2 receptors. J Pharmacol Exp Ther 2002; 302: 381-389. (Pubitemid 34680462)
18. Padala PR, Sadiq HJ, Padala KP. Urinary obstruction with citalopram and aripiprazole combination in an elderly patient. J Clin Psychopharmacol 2006; 26: 667-8. (Pubitemid 44772749)